Lakewood-Amedex Biotherapeutics Inc. Shareholders' Equity
Lakewood-Amedex Biotherapeutics Inc. (LABT) had Shareholders' Equity of $4.33 million as of 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-18
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.33M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$2.84M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.96M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$683.25K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $4.33M S-1 · filed 2026-09-18 |
| 2026-03-31 | -$2.84M S-1 · filed 2026-09-18 |
| 2025-12-31 | -$1.96M S-1 · filed 2026-09-18 |
| 2025-06-30 | -$683.25K S-1 · filed 2026-09-18 |
| 2025-03-31 | -$76.23K S-1 · filed 2026-09-18 |
| 2024-12-31 | $409.61K S-1 · filed 2026-09-18 |
| 2023-12-31 | $4.56M S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B |